Compare Jubilant Pharmova with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA GSK PHARMA JUBILANT PHARMOVA /
GSK PHARMA
 
P/E (TTM) x 12.9 58.4 22.0% View Chart
P/BV x 1.9 19.3 9.8% View Chart
Dividend Yield % 0.9 1.8 50.8%  

Financials

 JUBILANT PHARMOVA    GSK PHARMA
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-21
GSK PHARMA
Mar-21
JUBILANT PHARMOVA /
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0471,805 58.0%   
Low Rs2511,155 21.8%   
Sales per share (Unadj.) Rs559.1188.8 296.1%  
Earnings per share (Unadj.) Rs51.821.1 244.8%  
Cash flow per share (Unadj.) Rs80.125.8 310.3%  
Dividends per share (Unadj.) Rs5.0030.00 16.7%  
Avg Dividend yield %0.82.0 38.0%  
Book value per share (Unadj.) Rs297.688.5 336.4%  
Shares outstanding (eoy) m159.28169.41 94.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.27.8 14.8%   
Avg P/E ratio x12.570.0 17.9%  
P/CF ratio (eoy) x8.157.3 14.1%  
Price / Book Value ratio x2.216.7 13.0%  
Dividend payout %9.7141.9 6.8%   
Avg Mkt Cap Rs m103,365250,695 41.2%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7286,147 353.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m89,05531,989 278.4%  
Other income Rs m2981,106 27.0%   
Total revenues Rs m89,35433,094 270.0%   
Gross profit Rs m18,6995,227 357.7%  
Depreciation Rs m4,516793 569.7%   
Interest Rs m2,47335 7,003.4%   
Profit before tax Rs m12,0085,505 218.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7641,924 195.7%   
Profit after tax Rs m8,2443,581 230.2%  
Gross profit margin %21.016.3 128.5%  
Effective tax rate %31.334.9 89.7%   
Net profit margin %9.311.2 82.7%  
BALANCE SHEET DATA
Current assets Rs m29,52522,027 134.0%   
Current liabilities Rs m10,48813,325 78.7%   
Net working cap to sales %21.427.2 78.6%  
Current ratio x2.81.7 170.3%  
Inventory Days Days1347 26.7%  
Debtors Days Days34246 13.7%  
Net fixed assets Rs m58,1098,076 719.5%   
Share capital Rs m1591,694 9.4%   
"Free" reserves Rs m47,24813,297 355.3%   
Net worth Rs m47,40714,991 316.2%   
Long term debt Rs m25,6400-   
Total assets Rs m87,63430,102 291.1%  
Interest coverage x5.9156.9 3.7%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.01.1 95.6%   
Return on assets %12.212.0 101.8%  
Return on equity %17.423.9 72.8%  
Return on capital %19.837.0 53.6%  
Exports to sales %00-   
Imports to sales %10.20.9 1,188.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m9,117276 3,307.2%   
Fx inflow Rs m11,207278 4,031.0%   
Fx outflow Rs m9,117276 3,307.2%   
Net fx Rs m2,0902 88,559.3%   
CASH FLOW
From Operations Rs m17,8435,779 308.7%  
From Investments Rs m-7,3904,186 -176.5%  
From Financial Activity Rs m-17,094-6,961 245.6%  
Net Cashflow Rs m-7,2893,004 -242.6%  

Share Holding

Indian Promoters % 46.5 0.0 -  
Foreign collaborators % 4.2 75.0 5.5%  
Indian inst/Mut Fund % 24.2 12.8 189.3%  
FIIs % 23.1 2.0 1,134.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 25.0 197.3%  
Shareholders   113,776 123,480 92.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Jan 19, 2022 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - MESCO PHARMA COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS